» Articles » PMID: 39458839

Exploring the Antidiabetic Potential of Using Network Pharmacology, Molecular Docking and ADME/Drug-Likeness Predictions

Overview
Journal Plants (Basel)
Date 2024 Oct 26
PMID 39458839
Authors
Affiliations
Soon will be listed here.
Abstract

A combination of network pharmacology, molecular docking and ADME/drug-likeness predictions was employed to explore the potential of compounds to interact with key targets involved in the pathogenesis of T2DM. These were predicted using the SwissTargetPrediction, Similarity Ensemble Approach and BindingDB databases. Networks were constructed using the STRING online tool and Cytoscape (v.3.9.1) software. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis and molecular docking were performed using DAVID, SHINEGO 0.77 and MOE suite, respectively. ADME/drug-likeness parameters were computed using SwissADME and Molsoft L.L.C. The top-ranking targets were CTNNB1, JUN, ESR1, RELA, NR3C1, CREB1, PPARG, PTGS2, CYP3A4, MMP9, UGT2B7, CYP2C19, SLCO1B1, AR, CYP19A1, PARP1, CYP1A2, CYP1B1, HSD17B1, and GSK3B. Apigenin, caffeic acid, oleanolic acid, rosmarinic acid, hispidulin, and salvianolic acid B showed the highest degree of connections in the compound-target network. Gene enrichment analysis identified pathways involved in insulin resistance, adherens junctions, metabolic processes, IL-17, TNF-α, cAMP, relaxin, and AGE-RAGE in diabetic complications. Rosmarinic acid, caffeic acid, and salvianolic acid B showed the most promising interactions with PTGS2, DPP4, AMY1A, PTB1B, PPARG, GSK3B and RELA. Overall, this study enhances understanding of the antidiabetic activity of and provides further insights for future drug discovery purposes.

References
1.
Zhu C, Cai T, Jin Y, Chen J, Liu G, Xu N . Artificial intelligence and network pharmacology based investigation of pharmacological mechanism and substance basis of Xiaokewan in treating diabetes. Pharmacol Res. 2020; 159:104935. DOI: 10.1016/j.phrs.2020.104935. View

2.
Teli D, Gajjar A . Glycogen synthase kinase-3: A potential target for diabetes. Bioorg Med Chem. 2023; 92:117406. DOI: 10.1016/j.bmc.2023.117406. View

3.
Menezes da Costa R, Neves K, Mestriner F, Louzada-Junior P, Bruder-Nascimento T, Tostes R . TNF-α induces vascular insulin resistance via positive modulation of PTEN and decreased Akt/eNOS/NO signaling in high fat diet-fed mice. Cardiovasc Diabetol. 2016; 15(1):119. PMC: 5000486. DOI: 10.1186/s12933-016-0443-0. View

4.
Malik A, Morya R, Bhadada S, Rana S . Type 1 diabetes mellitus: Complex interplay of oxidative stress, cytokines, gastrointestinal motility and small intestinal bacterial overgrowth. Eur J Clin Invest. 2018; 48(11):e13021. DOI: 10.1111/eci.13021. View

5.
Zieba A, Stepnicki P, Matosiuk D, Kaczor A . What are the challenges with multi-targeted drug design for complex diseases?. Expert Opin Drug Discov. 2022; 17(7):673-683. DOI: 10.1080/17460441.2022.2072827. View